which provide health benefits without directly involving intestinal
microbiota (Takano, 2002).
Some of the most investigated groups of biogenics are the
bioactive peptides that are released from food proteins as the result
of microbial proteolysis during fermentation. Upon oral administration,
bioactive peptides may affect different target systems in the
body, also depending on their amino acid sequence. The most
attractive sub-group of bioactive peptides are Angiotensin-I Converting
Enzyme (ACE)-inhibitory peptides. Several in vivo studies
have demonstrated the antihypertensive effect of ACE-inhibitory
peptides contained in dairy products (for a review see Usinger,
Ibsen, & Jensen, 2009).
which provide health benefits without directly involving intestinal
microbiota (Takano, 2002).
Some of the most investigated groups of biogenics are the
bioactive peptides that are released from food proteins as the result
of microbial proteolysis during fermentation. Upon oral administration,
bioactive peptides may affect different target systems in the
body, also depending on their amino acid sequence. The most
attractive sub-group of bioactive peptides are Angiotensin-I Converting
Enzyme (ACE)-inhibitory peptides. Several in vivo studies
have demonstrated the antihypertensive effect of ACE-inhibitory
peptides contained in dairy products (for a review see Usinger,
Ibsen, & Jensen, 2009).
การแปล กรุณารอสักครู่..